Van Mierloo et al.
JOCArticle
aqueous HCl solution (2.0 M) at 0 ꢀC and subsequently vigor-
ously stirred for an additional 3 h at rt. The organic phase was
separated and the aqueous phase was extracted with diethyl
ether. The combined organic phases were washed with a satu-
1H), 7.02 (d, J = 5.3 Hz, 1H), 1.92 (s, 1H), 1.80-1.64 (m, 4H),
1.57-1.50 (m, 2H), 0.91 (d, J = 6.3 Hz, 6H), 0.71 (d, J = 6.6 Hz,
1
3
6H); C NMR (75 MHz, CDCl
3
) δ 145.7, 135.6, 129.5 (CH),
128.8 (CH), 128.4, 127.3 (CH), 126.8 (CH), 124.9 (CH), 79.3
-1
rated bicarbonate solution and brine, dried with MgSO
evaporated under reduced pressure to give a yellow oil. The
4
, and
2 3 3
(C-OH), 52.7 (CH ), 24.6 (CH ), 24.4 (CH ); IR (NaCl, cm )
ν
max 3587 (m, OH), 3106/3074 (w, unsaturatedC-H), 2955/2928/
-
2
crude oil was purified by vacuum distillation (75 ꢀC, 10 mbar)
resulting in a pure slightly yellow oil (4.51 g, 32%). GC-MS (EI)
2868 (s, saturated C-H).
7-([2,2 -Bithiophen]-3-yl)-5-ethylpentadecan-7-ol (11d). 11d was
obtained according to general procedure 1 with 3-bromo-2,2 -
0
þ
0
m/z 254 [M ]; HRMS (EI) calcd for C17
m/z 254.2612; H NMR (300 MHz, CDCl
H
34O 254.2610, found
1
3
) δ 2.37 (t, J = 7.5 Hz,
bithiophene (9) (1.00 g, 4.08 mmol), dry diethyl ether (70 mL),
n-BuLi (1.6 M in hexane, 2.50 mL, 4.08 mmol), and 5-ethylpenta-
decan-7-one (10d) (1.00 g, 4.08 mmol); eluent gradient hexane to
2
2
H), 2.30 (d, J = 6.6 Hz, 2H), 1.89-1.81 (m, 1H), 1.60-1.53 (m,
13
H), 1.26-1.18 (m, 18H), 0.91-0.81 (m, 9H); C NMR (75
) δ 212.0 (CO), 47.6 (CH ), 43.5 (CH ), 35.3 (CH),
), 32.0 (CH ), 29.6 (CH ), 29.4 (CH ), 29.3 (CH ), 29.0
MHz, CDCl
3.3 (CH
3
2
2
hexane/ethyl acetate 90:10; yield 34% (0.583 g). GC-MS (EI) m/z
420.2521, found m/z
þ
3
2
2
2
2
2
420 [M ]; HRMS (EI) calcd for C25
H
40OS
2
1
(
(
CH ), 26.5 (CH ), 24.0 (CH ), 23.1 (CH ), 22.8 (CH ), 14.2
2
420.2492; H NMR (300 MHz, CDCl ) δ7.37 (dd, J =5.2/1.2Hz,
2
2
2
2
3
-
1
CH
3
), 11.0 (CH
3
), 10.9 (CH
3
); IR (NaCl, cm ) νmax 2959/
1H), 7.24 (d, J = 5.3 Hz, 1H), 7.10 (dd, J = 3.5/1.2 Hz, 1H), 7.02
(dd, J = 5.2/3.5 Hz, 1H), 6.97 (d, J = 5.3 Hz, 1H), 1.93 (s, OH),
2
926/2859 (s, saturated C-H), 1717 (m, CO).
0
13
3-([2,2 -Bithiophen]-3-yl)pentan-3-ol (11a): General Procedure
A solution of 3-bromo-2,2 -bithiophene (9) (3.0 g, 12 mmol) in
1.77-1.58 (m, 4H), 1.44-1.05 (m, 21H), 0.89-0.69 (m, 9H); C
0
1
dry diethyl ether (100 mL) was added slowly to a solution of
NMR (75 MHz, CDCl ) δ 145.7, 135.7, 129.5 (CH), 128.7, 128.5
3
(CH), 127.3 (CH), 126.8 (CH), 124.9 (CH), 78.8 (C-OH), 47.7
(CH ), 43.4 (CH ), 34.7 (CH), 33.9 (CH ), 32.0 (CH ), 29.7 (CH ),
2 2 2 2 2
29.4 (CH ), 28.7 (CH ), 27.1 (CH ), 23.7 (CH ), 23.22 (CH ),
2 2 2 2 2
n-BuLi (1.6 M in hexane, 7.5 mL, 12 mmol) in dry diethyl ether
(
100 mL) at-78ꢀC over 2 hunderN . The mixturewas stirred for
2
1
(
5 min at the same temperature. Freshly distilled 3-pentanone
1.29 mL, 12 mmol) was added via a syringe to the mixture at
23.16 (CH ), 22.8 (CH ), 14.2 (CH ), 10.7 (CH ), 10.6 (CH ); IR
2 2 3 3 3
-
1
(NaCl, cm ) νmax 3589/3490 (m, OH), 3105/3073 (w, unsaturated
C-H), 2956/2926/2856 (s, saturated C-H).
6-([2,2 -Bithiophen]-3-yl)undecan-6-ol (11e). 11e was obtained
-
quenched with an aqueous NH Cl solution (2.5 M) and water
78 ꢀC, followed by stirring overnight at rt. The reaction was
0
4
0
at 0 ꢀC. The organic phase was separated and the aqueous phase
was extracted with diethyl ether. The combined organic phases
according to general procedure 1 with 3-bromo-2,2 -bithiophene
(9) (0.500 g, 2.04 mmol), dry diethyl ether (40 mL), n-BuLi (1.6 M
were washed with brine, dried with MgSO , and concentrated
4
in hexane, 1.25 mL, 2.04 mmol), and 6-undecanone (0.42 mL, 2.04
mmol); eluent hexane/ethyl acetate 90:10; yield 62% (0.425 g).
under reduced pressure to give a crude oil. The oily residue was
purified by column chromatography (silica, eluent hexane/ethyl
acetate 90:10) to afford the title compound as a slightly yellow oil
þ
GC-MS (EI) m/z 336 [M ]; HRMS (EI) calcd for C19
H
28OS
2
1
336.1582, found m/z 336.1580; H NMR (300 MHz, CDCl
3
) δ
þ
(
C H OS 252.0643; found m/z 252.0652; H NMR (300 MHz,
1.7 g, 56%). GC-MS (EI) m/z 252 [M ]; HRMS (EI) calcd for
7.37 (d, J = 5.2/1.3 Hz, 1H), 7.25 (d, J = 5.4 Hz, 1H), 7.10 (dd,
J = 3.5/1.3 Hz, 1H), 7.02 (dd, J = 5.2/3.5 Hz, 1H), 6.99 (d, J =
5.4 Hz, 1H), 1.80-1.59 (m, 4H), 1.26-1.16 (m, 12H), 0.85 (t, J =
1
1
3
16
2
CDCl
7
(
3
) δ 7.37 (dd, J = 5.0/1.2 Hz, 1H), 7.26 (d, J = 5.4 Hz, 1H),
13
.13 (dd, J = 3.4/1.2 Hz, 1H), 7.03 (dd, J = 5.0/3.4 Hz, 1H), 6.98
d, J = 5.4 Hz, 1H), 2.01 (s, 1H), 1.82-1.69 (m, 4H), 0.83 (t, J =
3
7.1 Hz, 6H); C NMR (75 MHz, CDCl ) δ 145.5, 135.6, 129.4
(CH), 128.7, 128.4 (CH), 127.3 (CH), 126.8 (CH), 124.9 (CH),
78.2 (C-OH), 43.1 (CH ), 32.3 (CH ), 23.5 (CH ), 22.7 (CH ),
13
7
.4 Hz, 6H); C NMR (75 MHz, CDCl ) δ 144.8, 135.6, 129.5
3
2
2
2
2
-1
(
7
CH), 129.2, 128.4 (CH), 127.3 (CH), 126.9 (CH), 125.0 (CH),
3
14.2 (CH ); IR (NaCl, cm ) νmax 3584/3474 (m, OH), 3104/3073
-1
2 3
8.8 (C-OH), 35.3 (CH ), 8.3 (CH ); IR (NaCl, cm ) νmax 3584
(w, unsaturated C-H), 2954/2929/2859 (s, saturated C-H).
1-([2,2 -Bithiophen]-3-yl)cyclohexanol (11f). 11f was obtained
0
(
(
w, OH), 3105/3073 (w, unsaturatedC-H), 2966/2931/2877/2854
0
m, saturated C-H).
according to general procedure 1 with 3-bromo-2,2 -bithiophene
(9) (0.50 g, 2.04 mmol), dry diethyl ether (40 mL), n-BuLi (1.6 M
0
2-([2,2 -Bithiophen]-3-yl)undecan-2-ol (11b). 11b was obtained
according to general procedure 1 with 3-bromo-2,2 -bithiophene
0
in hexane, 1.25 mL, 2.04 mmol), and cyclohexanone (0.21 mL,
2.04 mmol); eluent hexane/ethyl acetate 90:10; yield 49% (0.264
(
9) (1.00 g, 4.08 mmol), dry diethyl ether (70 mL), n-BuLi (1.6 M in
þ
hexane, 2.50 mL, 4.0 mmol), and 2-undecanone (0.84 mL, 4.08
mmol); eluent hexane/ethyl acetate 90:10; yield 63% (0.86 g). GC-
MS (EI) m/z 336 [M ]; HRMS (EI) calcd for C H OS
g). GC-MS (EI) m/z 264 [M ]; HRMS (EI) calcd for C14
H
16OS
2
1
264.0643, found m/z 264.0648; H NMR (300 MHz, CDCl
3
) δ
þ
7.37 (dd, J = 5.2/1.2 Hz, 1H), 7.24 (d, J = 5.4 Hz, 1H), 7.18 (dd,
J = 3.6/1.2 Hz, 1H), 7.11 (d, J = 5.4 Hz, 1H), 7.04 (dd, J = 5.2/
19
28
2
1
3
36.1582, found m/z 336.1583; H NMR (300 MHz, CDCl ) δ
3
13
7.37 (dd, J = 5.1/1.1 Hz, 1H), 7.24 (d, J = 5.4 Hz, 1H), 7.14 (dd,
J = 3.5/1.1 Hz, 1H), 7.07 (d, J = 5.4 Hz, 1H), 7.03 (dd, J = 5.1/
3.6 Hz, 1H), 1.87-1.82 (m, 4H), 1.70-1.50 (m, 6H); C NMR
(75 MHz, CDCl ) δ 147.7, 136.0, 130.0, 129.5 (CH), 127.6 (CH),
127.2 (CH), 127.0 (CH), 124.9 (CH), 73.5 (C-OH), 39.0 (CH ),
3
3
.5 Hz, 1H), 2.12 (s, 1H), 1.82-1.68 (m, 2H), 1.51 (s, 3H),
2
13
-1
1
.28-1.15 (m, 14H), 0.89 (t, J = 6.6 Hz, 3H); C NMR (75
) δ 146.8, 135.6, 129.5 (CH), 129.0, 128.1 (CH), 127.2
CH), 126.9 (CH), 124.8 (CH), 75.2 (C-OH), 44.0 (CH ), 32.0
), 24.3
); IR (NaCl, cm ) νmax 3451 (m,
2 2
25.5 (CH ), 22.1 (CH ); IR (NaCl, cm ) νmax 3553/3441 (m,
MHz, CDCl
3
OH), 3104(w, unsaturated C-H), 2932/2851(s, saturated C-H).
9-([2,2 -Bithiophen]-3-yl)heptadecan-9-ol (11g). 11g was ob-
0
(
(
(
2
0
CH
CH
2
), 30.4 (CH
), 22.8 (CH
2
), 30.0 (CH
), 14.2 (CH
2
), 29.6 (CH
2
), 29.4 (CH
2
tained according to general procedure 1 with 3-bromo-2,2 -
-
1
bithiophene (9) (5.00 g, 20 mmol), dry diethyl ether (340 mL),
n-BuLi (1.6 M in hexane, 12.8 mL, 20 mmol), and heptadecan-9-
one (5.08 g, 20 mmol); eluent gradient hexane to hexane/ethyl
2
2
3
OH), 3105/3087/3074 (w, unsaturated C-H), 2955/2925/2854 (s,
saturated C-H).
þ
0
4-([2,2 -Bithiophen]-3-yl)-2,6-dimethylheptan-4-ol (11c). 11c
was obtained according to general procedure 1 with 3-bromo-
acetate (90:10); yield 75% (6.3 g). GC-MS (EI) m/z 420 [M ];
HRMS (EI) calcd for C25
H
40OS
420.2521, found m/z 420.2521;
2
0
1
2
n-BuLi (1.6 M in hexane, 7.50 mL, 12 mmol), and 2,6-dimethyl-4-
,2 -bithiophene(9) (3.00 g, 12 mmol), dry diethyl ether (200 mL),
H NMR (300 MHz, CDCl ) δ 7.37 (dd, J = 5.2/1.1 Hz, 1H),
3
7.24 (d, J = 5.3 Hz, 1H), 7.10 (dd, J = 3.5/1.1 Hz, 1H), 7.02 (dd,
J = 5.3/3.5 Hz, 1H), 7.00 (d, J = 5.3 Hz, 1H), 1.98 (s, 1H),
heptanone(2.17mL, 12 mmol); eluent hexane/ethylacetate 90:10;
yield 18% (0.67 g). GC-MS (EI) m/z 308 [M ]; HRMS (EI) calcd
þ
1.78-1.63 (m, 4H), 1.31-1.14 (m, 24H), 0.87 (t, J = 6.6 Hz,
1
13
for C17
MHz, CDCl
Hz, 1H), 7.10 (dd, J = 3.6/1.3 Hz, 1H), 7.03 (dd, J = 5.2/3.6 Hz,
H
24OS
2
308.1269, found m/z 308.1264; H NMR (300
3
6H); C NMR (75 MHz, CDCl ) δ 145.6, 135.6, 129.4 (CH),
3
) δ 7.37 (dd, J = 5.2/1.3 Hz, 1H), 7.25 (d, J = 5.3
128.7, 128.4 (CH), 127.3 (CH), 126.8 (CH), 124.9 (CH), 78.2
(C-OH), 43.1 (CH ), 32.0 (CH ), 30.1 (CH ), 29.7 (CH ), 29.4
2
2
2
2
J. Org. Chem. Vol. 75, No. 21, 2010 7207